Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction

Autor: Peter Sylvanus Ndow, Mamadou Kourna Hama, Brenda Kwambana-Adams, Dam Khan, Joseph Nsiari-Muzeyi Biey, Boubou Laouali, Moussa Haladou, Archibald Worwui, Catherine Okoi, Ricardo Nse Obama, Bernard Ntsama, Jason M. Mwenda, Martin Antonio, Abdoulaye Yam

Publikováno v: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

Background Meningitis is endemic in Niger. Haemophilus influenzae type b (Hib) vaccine and the 13-valent pneumococcal conjugate vaccine (PCV13) were introduced in 2008 and 2014, respectively. Vaccination campaign against Neisseria meningitidis serogr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b87113517d0024fce8b58b5ae12fa411
https://doi.org/10.1093/cid/ciz598

Epidemiological, clinical and biological features of malaria among children in Niamey, Niger

Autor: Ibrahim Maman, Gagara Moussa, Lacroix Véronique, Adehossi Eric, Gay-Andrieu Françoise, Kourna Hama, Boureima Hamadou

Publikováno v: Malaria Journal
Malaria Journal, Vol 4, Iss 1, p 10 (2005)

Background Malaria takes a heavy toll in Niger, one of the world's poorest countries. Previous evaluations conducted in the context of the strategy for the Integrated Management of Childhood Illness, showed that 84% of severe malaria cases and 64 % o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6f3842d114240c98924dd6076bbbff9d
https://pubmed.ncbi.nlm.nih.gov/15703076

Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction.

Autor: Kourna Hama M; Laboratoire Hopital National de Niamey, Niger., Khan D; World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, United Kingdom., Laouali B; Laboratoire Hopital National de Niamey, Niger., Okoi C; World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, United Kingdom., Yam A; WHO Country Office, Niamey, Niger., Haladou M; WHO Country Office, Niamey, Niger., Worwui A; World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, United Kingdom., Ndow PS; World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, United Kingdom., Nse Obama R; WHO Country Office, Niamey, Niger., Mwenda JM; WHO Regional Office for Africa, Brazzaville, Republic of Congo., Biey J; WHO Regional Office for Africa, Brazzaville, Republic of Congo., Ntsama B; WHO Intercountry Support Team for West Africa, Ouagadougou, Burkina Faso., Kwambana-Adams BA; World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, United Kingdom., Antonio M; World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, United Kingdom.; Microbiology and Infection Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 Sep 05; Vol. 69 (Suppl 2), pp. S133-S139.